SRI-22818
SRI-22818 is a NF-κB activator with an EC50 of 0.5 μM. SRI-22818 upregulates the expression of NF-κB and promotes its activation. SRI-22818 increases the level of SOD2. SRI-22818 exhibits activity in the SOD1G93A model of amyotrophic lateral sclerosis (ALS). SRI-22818 can be used for research related to amyotrophic lateral sclerosis.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1429221-68-0
- Fòrmula: C16H12BrNO3
- Peso molecular:346.18
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| SH-SY5Y | EC50 |
0.5 μM
Compound: Example 1
|
Activation of NF-KappaB (unknown origin) expressed in SH-SY5Y cells co-transfected with pNFkappaB-Luc plasmid measured after 24 hrs by Bright-Glo luciferase assay
Activation of NF-KappaB (unknown origin) expressed in SH-SY5Y cells co-transfected with pNFkappaB-Luc plasmid measured after 24 hrs by Bright-Glo luciferase assay
|
[PMID: 31857831] |
In Vitro
Chemical Information
-
No. CAS 1429221-68-0
-
Peso molecular 346.18
-
Fòrmula C16H12BrNO3
-
SMILES
BrC(C=CC=C1)=C1N/C=C\C(C2=CC=C(OCO3)C3=C2)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)